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Abstract The genes encoding the rabbit 5HTlo~ and 5HTma 
receptors have been cloned. The deduced amino acid sequence of 
these receptors hows 91-92% amino acid sequence identity with 
their human homologues, and similar high sequence identity with 
homologues from other species. The receptors were transiently 
expressed in COS-7 cells and exhibit a pharmacological profile 
closely resembling their human homologues, including a higher 
affinity of ketanserin for the 5-HTm, ~ subtype. However, suma- 
triptan had a lower affinity for both the rabbit receptors com- 
pared to their human counterparts. This may be accounted for by 
differences between the primary amino acid sequences of these 
species homologues. 
Key words: G-protein coupled receptor; Serotonin; 
5-Hydroxytryptamine; Rabbit 
I. Introduction 
5-HT (serotonin) is a biogenic amine neurotransmitter which 
has diverse physiological ctions in both the central and periph- 
eral nervous ystems. Multiple 5-HT receptors exist, which can 
be characterised by their amino acid sequence, pharmacology 
and functional coupling to second messengers. Five members 
of the human 5-HT 1 subfamily of receptors have been cloned: 
5-HTIA, 5-HTID ~, 5-HTID p, 5-HT1E and 5-HTlF [1,2]. The 
human 5-HTxo ~ and 5-HT~Dp receptors have similar pharma- 
cological profiles, but only 65% identity in their amino acid 
sequence. The rat 5-HT~R receptor is the species homologue of 
the human 5-HT1Dp receptor. These proteins have 93% amino 
acid sequence identity but distinct pharmacological profiles [3]. 
All members of the 5-HT~ receptor subfamily have been shown 
to couple negatively to adenylate cyclase demonstrated byfunc- 
tional analysis in cell lines and can be characterised by distinct 
pharmacological profiles [1,2]. 
Early studies demonstrated the therapeutic utility of 5-HT in 
the treatment of migraine [4]. Sumatriptan, a treatment for 
acute migraine, is a selective 5-HT~ agonist and mediates vaso- 
constriction of cranial blood vessels [5]. Sumatriptan binds with 
high affinity to cloned human 5-HTlo~, 5-HTxo p and 5-HTxF 
receptors expressed in cell lines [6,7], implicating these recep- 
tors as possible targets for migraine therapy. 
The pharmacology of 5-HTl-like receptors that mediate vas- 
oconstriction has been studied in a variety of tissues from 
several species, including man, dog, and rabbit (for a review see 
[8]). In the rabbit saphenous vein, 5-HTl-like receptors alone 
appear to mediate vasoconstriction, and in contrast o other 
species, ketanserin has a relatively high affinity for this receptor 
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[9]. In order to begin to explore the molecular basis for any 
differences in pharmacology between the human and rabbit 
5-HT1D receptors, we report here the molecular cloning of rab- 
bit 5-HT1D~ and 5-HTID~ receptors and their transient expres- 
sion in COS-7 cells. 
2. Experimental 
2.1. Isolation and characterisation of genomic lones 
A genomic DNA library constructed in AEMBL3 SP6/T7 from rabbit 
liver (Clontech) was screened using as probes fragments containing the 
entire cloned human 5-HT1D~ or 5-HT1Dp genes. Probes were labelled 
by random priming with [cz-32p]d-ATP (Amersham) and hybridised at 
65°C for 16 h in 4 x SSC, 4 x Denhardts, 0.1% SDS, 50/.tg/ml salmon 
sperm DNA with library filter lifts made onto Colony/Plaque screen 
membranes (NEN/DuPont). Filters were washed at 65°C in 0.7 x SSC, 
0.1% SDS. Positive plaques were purified, and characterised by restric- 
tion mapping and Southern blotting of bacteriophage DNA. Hybridis- 
ing fragments were subcloned into pUC18 (Pharmacia), and DNA was 
directly sequenced using the Sequenase version 2.0 DNA sequencing kit 
(USB). 
2.2. Cell culture and membrane preparation 
COS-7 cells were maintained at37°C with 5% COs in Iscove's mod- 
ified Dulbecco's medium with glutamine supplemented with 10% foetal 
calf serum and 1% non-essential amino acids (all from Gibco). The 
expression constructs pSVL/rab5-HT1D ~ or pSVL/rab5-HT~I~ were 
transfected into the cells using 0.5 mg/ml DEAE Dextran with an 
additional 2.5 h treatment with 100 pM chloroquine followed by a 
2 rain shock with 10% DMSO [10]. The cells were incubated for 72 h 
and were scraped into preparation buffer (50 mM Tris-HC1 pH 7.4, 
1 mM EDTA, 1 mM EGTA, 6 mM MgC12), homogenised (Ultraturax) 
and centrifuged at 135,000 x g for 60 min. The membrane pellet was 
resuspended in assay buffer (50 mM Tris-HC1 pH 7.4, 4 mM 
CaC12-2H20 , 1% ascorbic acid, 10 pM pargyline), rehomo- 
genised in a Dounce homogeniser and protein concentration assayed 
(Bio-Rad). 
2.3. Radioligand binding assay 
For radioligand binding 30-120 pg of protein, 1.5 nM [3H]5-HT and 
increasing concentrations of competing drug or assay buffer in a total 
assay volume of 1 ml were incubated at 27°C for 30 min. Incubations 
were terminated by rapid filtration (Brande124 well harvester) through 
GFB glassfibre filters (Whatman). The filters were washed twice with 
5 ml ice cold 50 mM Tris-HC1 pH 7.4, and filter discs counted in 
Optiphase 'Hisafe' (Wallac). Competition binding data were analysed 
by fitting to a three parameter logistic function to provide pICs0 esti- 
mates. Saturation binding analysis used doubling concentrations of 
[3H]5-HT from 0.025-50 nM in the absence or presence of 10ARM cold 
5-HT to measure non-specific binding. Total binding data were fitted 
to a hyperbola plus a straight line function to obtain estimates of Kd, 
Hill slope parameters and Bma x. Non-specific binding data were fitted 
to a straight line function. 
2.4. Drugs used 
5-Hydroxytryptamine hydrochloride (Sigma), 5-carboxyamidotryp- 
tamine maleate (Tocris Cookson), ketanserin (RBI), pindolol (Sigma), 
metergoline (Farmitalia Carlo ERBA). Sumatriptan was synthesised by 
the Medicinal Chemistry Department a the Wellcome Research Labo- 
ratories. All drugs were dissolved in 2 mM HC1. Further dilutions were 
made in assay buffer. 
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A • • 
Rabbit MSPSNQSAEG LPQEAANRSL 
Human MSPLNQSAEG LPQEASNRSL 
Canine MSPPNQSLEG LLQEASNRSL 
Rat MSLPNQSLEG LPQEASNRSL 
Rabbit ATVLSNTFVL TTILLTRKLH 
Human ATVLSNAFVL TTILLTRKLH 
Can ine  ATALSNAFVL TT IFLTRKLH 
Rat ATVLSNAFVL TTILLTKKLH 
********** ****** 
Rabbit THTWNFGQ~IL CDIWVSSDIT 
Htunan THTWNFGQIL CDIWLSSDIT 
Canine TRTWSFGQIL CDIWLSSDIT 
Rat TRTWNFGQIL CDIWVSSDIT 
**** ********** 
[] 
Rabbit TAGHAIh~MIA VVWAISICIS 
Human TAGHAATMIA IVWAISICIS 
Canine TAGRAAVMIA TVWVISICIS 
Rat TAGHAAAMIA AVWAISICIS 
******* ********** 
TMIV 
Rabbit STCGAFYIPS VLLIVLYGRI 
Human STCGAFYIPS VLLI ILYGRI 
Canine STCGAFYIPS VLLI ILYGRI 
Rat STCGAFYIPS ILLIILYGRI 
********** ********** 
TMV 
Rabbit SSLCSLSPSL GEGHSHSAGS 
Human SSLCSLNSSL HEGHSHSAGS 
Canine SSLCSLSPSL QEERSHAAGP 
Rat SSLCSLNPSL HESHTHTVGS 
Rabbit KTLGIILGAF IGCWLPFFVA 
Human KILGI ILGAF I ICWLPFFW 
Can ine  KTLGI ILGAF  IVCWLPFFVA 
Rat KTLGI ILGAF  I ICWLPFFVV 
*ee******  **e**e****  
TMVI 
Rabb i t  INP I IYTVFN EDFRQAFQRV 
Human INPI IYTVFN EEFRQAFQKI 
Can ine  INP I IYTWN EEFRQAFQRV 
Rat INPVIYTVFN EDFRQAFQRV 
******** 
V 
NATGTPEAWD PGTLQALKIS LAVVLSI ITV 
NATETSEAWD PRTLQALKIS LAVVLSVITL 
NATETPEAWG PETLQALK IS  LALLLS I ITM 
NATG.. .AWD PEVLQALRIS LVVVLSI ITL 
******* ********** 
TMI 
TP/~IYL IGSL  ATTDLLVS IL  V I~ IS IAYT I  
TPANYLIGSL ATTDLLVSIL VMPISIAYTI  
TP/~NYLIGSL .~ ITDLLVS IL  VMPIS IAYTT 
TPANYLIGSL ATTDLLVSIL VMPISIAYTT 
******* ********** ********* 
TMI I  
CCTASILHLC VIALDRYWAI TDALEYSKRR 
CCTASILHLC VIALDRYWAI TDALEYSKRR 
CCTASILHLC VIALDRYWAI TDALEYSKRR 
CCTASILHLC VIALDRYWAI TDALEYSKRR 
**********  ****  
TMIII 
IPPLFWRQAK AHEEVSDCLV NTSQISYT IY  
IPPLFWRQAK AQEEMSDCLV NTSQISYTIY 
IPPLFWRQAK AQEDMSDCQV NTSQISYT IY  
IPPLFWRQAT AHEEMSDCLV NTSQISYTIY 
**** ***** 
r"n 
YM~AP~NRILN PPSLYGKRFT TAHLITGSAG 
YRAARNRILN PPSLYGKRFT TAHLITGSAG 
YVAARNRILN PPSLYGKRFT TAQLITGSAG 
YV~h~RSRILN PPSLYGKRFT TAQLITGSAG 
[=3 1:3 
PLFFNPVRIK LADSVLERKR ISAARERKAT 
PLFFNHVKIK LADSALERKR IS i~RERI~T 
PLFFNHVQVK LAEGVLERKR ISAARERKAT 
PLFFNQVKIK L /~S ILERKR IS~RERKAT 
SLVLPICRDS C~PGLFDF FTWLGYLNSL 
SLVLPICRDS CWIHPALFDF FTWLGYLNSL 
SLVLPICRAS CWLHPALFDF FTWLGYLNSL 
SLVLPICRDS CWIHPALFDF FTWLGYLNSL 
******* ******* ********** 
TMVII 
IHFRKAF 
VPFRKAS 
VHVRKAS 
VHFRKAS 
8 
Rabbit MEEPSARCA. 
Human MEEPGAQCAP 
Mouse MEEQGIQCAP 
Rat MEEQGIQCAP 
Opossum MEQPSRLCSP 
V V 
PPLAGSQIAV PQANLSAAHS HNCSAEGY.I  YQDSIALPWK 
PPPAGSETWV PQANLSSAPS QNCSAKDY.I  YQDSISLPWK 
PpPAASQTGV PLTNLS .... HNCSADGY.I YQDSIALPWK 
PPPATSQTGV PLANLS .... HNCSADDY.I YQDSIALPWK 
P..ASGSLTS SQTNHSTFPN PNCSAPDLEP YQDSIALPWK 
******** 
Rabbit VLLVLLLALF 
Human VLLVMLLALI 
Mouse VLLVALLALI 
Rat VLLVALLALI 
Opossum VLLATFLGLI 
********** 
TMI 
Rabbit ILVMPISTMY TVTGRWTLGQ 
Human ILVMPISTMY TVTGRWTLGQ 
Mouse ILVMPISTMY TVTGRWTLGQ 
Rat ILVMPISTMY TVTGRWTLGQ 
Opossum ILVMPISTMY TVTGRWTLGQ 
********** , ** 
Rabbit AITDAVEYSA KRTPKRAAIM 
Human AITDAVEYSA KRTPKRAAVM 
Mouse AITDAVEYSA KRTPKRAAIM 
Rat AITDAVDYSA KRTPKRAAIM 
Opossum AITDAVEYSA KRTPKRAAGM 
Rabbit LVNTDHVLYT VYSTVGAFYL 
Human VVNTDHILYT VYSTVGAFYF 
Mouse FVNTDHVLYT VYSTVGAFYL 
Rat FVNTDHVLYT VYSTVGAFYL 
Opossum SVNTDHILYT VYSTVGAFYF 
*** ********** 
TMV 
[] 
Rabbit RLTRAQLITD SPGSTTSVTS 
Mouse RLTRAQLITD SPGSTSSVTS 
Rat RLTRAQLITD SPGSTSSVTS 
Human RLTRAQLITD SPGSTSSVTS 
Opossum RLTRAQLITD SPGSSSSGTS 
1 
TLATTLSNAF VVATVYRTRK LHTPANYLIA 
TLATTLSNAF VIATVYRTRK LHTPANYLIA 
TLATTLSNAF VIATVYRTRK LHTPANYLIA 
TLATTLSNAF VIATVYRTRK LHTPANYLIA 
TLGTTLSNAF VIATVSRTRK LHTPANYLIA 
********** ***** ***** 
VVCDLWLSSD ITCCTASIMH 
VVCDFWLSSD ITCCTASILH 
VVCDFWLSSD ITCCTASIMH 
VVCDFWLSSD ITCCTASINIt  
VVCDFWLSSD ITCCTASILH 
*********~ ********** 
TMIII 
IALVWVFSIC ISLPPFFWRQ 
IALVWVFSIS ISLPPFFWRQ 
IVLVWVFSIS  ISLPPFFWRQ 
IVLVWVFSIS ISLPPFFWRQ 
I IMVWVFSVS ISNPPLFWRQ 
**********  e*****  
TMIV 
PTLLLIALYG RIYVEARSRI 
PTLLL IALYG R IYVE/~SRI  
PTLLLIALYG RIYVEARSRI 
PTLLLIALYG RIYVEARSRI 
PTLLL IALYG RIYVE.~RSRI 
******e***  e 
SLAVTDLLVS 
SLAVTDLLVS 
SLAVTDLLVS 
SLAVTDLLVS 
SLAVTDLLVS 
********** 
TMII 
LCVIALDR~ 
LCVIALDRYW 
LCVIALDRYW 
LCVIALDRYW 
LCVIALDRYW 
******  
AKAEEEVSEC 
AKAEEEVSEC 
AKAEEEMLDC 
AKAEEEVLDC 
AKA.EEVADC 
LKQTPNRTGK 
LKQTPNRTGK 
LKQTPNKTGK 
LKQTPNKTGK 
LKQTPNRTGK 
INSRAPDVPS ESGSPVyVNQ VKVRVSDALL 
INSRAPDVPS ESGSPVYVNQ VKVRVSDALL 
INSRVPEVPS ESGSPVYVNQ VKVRVSDALL 
INSRVPDVPS ESGSPVYVNQ VKVRVSDALL 
INSRAPEGPS ESGSPVYVNQ VKVKVSDALL 
[:3 
Rabbit EKKKLMAARE RKATKTLGII  LGVFIVCWLP FFIISLVMPI CKDACWFHQA 
Human EKKKLMAARE RKATKTLGII  LGAFIVCWLP FFIISLVMPI CKDACWFHLA 
Mouse EKKKLMAARE RKATKTLGII LGAFIVCWLP FFIISLVMPI CKDACWFHMA 
Rat EKKKLMAARE RKATKTLGII  LGAFIVCWLP FFIISLVMPI CKDACWFHMA 
Opossum EKKKLM3{ARE RKATRTLGII  LGAFIVCWLP FFI ISLALPI CDDACWFHLA 
***** ********** ********** **** **** 
TMVI 
Rabbit IFDFFTWLGY VNSLINPI IY TMSNEDFKQA FHKLIRFKCT S 
Human IFDFFTWLGY LNSLINPI IY TMSNEDFKQA FHKLIRFKCT S 
Mouse IFDFFNWLGY LNSLINPI IY TMSNEDFKQA FHKLIRFKCA G 
Rat IFDFFNWLGY LNSLINPI IY TMSNEDFKQA FHKLIRFKCT G 
Opossum IFDFFNWLGY LNSLINPI IY TKSNDDFKQA FQKLMRFRRT S 
********** ********** • 
TMVII 
Fig. 1. (A) Comparison of amino acid sequences of 5-HT1D~ receptors. Alignment of the deduced amino acid sequences ofthe rabbit 5-HT~D~ receptor 
with the homologous human [6], rat [12] and canine [11] sequences. Putative transmembrane r gions (TMI-TMVII) are denoted by asterisks. In the 
amino-terminal region, consensus sites for glycosylation are indicated (*). Consensus ites for phosphorylation by protein kinases A (•) and C (n) 
are indicated. Amino acids in bold indicate residues in the rabbit sequence which differ from the corresponding residue in all other species. Sequences 
were aligned using the GCG suite of programmes. The nucleotide sequences were deposited with EMBL under accession umbers Z50162 and Z50163. 
(B) Comparison of amino acids sequences of 5-HTjoa receptors. Alignment of the deduced amino acid sequences of rabbit 5-HT~Dp receptor with 
the homologous human [6], rat [3], mouse [13] and opossum (kidney cell line) [14] receptor sequences. See Fig. 1A for explanation of symbols. 
3. Results 
3.1. Cloning of rabbit 5-HT~D~ and 5-HTlo p receptors 
A rabbit genomic library contructed in 2EMBL3 SP6/T7 was 
screened by probing with a 1.4 kb SspI EcoRI fragment con- 
taining the entire human 5-HT1D = gene. Two positive clones 
were obtained and one of these, clone 10, chosen for further 
analysis was found to contain a 4.5 kb HindlII fragment which 
included the entire rabbit 5-HT~D ~ gene. DNA sequence analy- 
sis revealed an open reading frame encoding 377 amino acids 
with high (91%) overall amino acid sequence identity to the 
human 5-HT~D~ receptor [6]. The homology to the human, 
canine and rat 5-HT~D~ recepeptors is shown in Fig. 1A. The 
same gene bank was screened for the the 5-HT 1D~ receptor gene 
using the human 5-HT1D ~ gene as a probe. Two partially over- 
lapping clones were isolated and used to construct a 1.35 kb 
NcoI-BamHI fragment encoding an open reading frame of 389 
amino acids with 92% amino acid identity to the human 
5- HT1Da receptor, [6] (Fig. 1B). Southern blot analysis using 
rabbit genomic DNA detected the presence of a single band of 
the predicted size with each probe (not shown). 
Hydropathy analysis of both these sequences predicted seven 
hydrophobic transmembrane spanning regions with a large 
third intracellular loop. This, together with the high amino acid 
sequence homologies to the human receptors, suggests these 
sequences encode the rabbit 5-HT1D~ and 5-HT1D~ receptors. 
All putative N-linked glycosylation sites are conserved within 
the N-terminal extracellular domains of each receptor, despite 
the presence of several unique amino acid substitutions within 
this region (Fig. 1A and B). 
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Fig. 2. Saturation binding of [3H]5-HT to rabbit 5-HTID ~ and 5-HT~Dp 
receptors. COS-7 cells were transfected with cloned 5-HT~D~ or 5-HTm~ 
receptors, membranes prepared and binding was measured after incu- 
bation with ligand for 30 rain. (A) 5-HTIo ~. (B) 5-HTm~. • = total 
binding; • = non-specific binding. 
3.2. Pharmacological nalys& 
The rabbit 5-HTIDc~ and 5-HT~Dp genes were subcloned into 
the expression vector pSVL (Pharmacia). The ligand binding 
properties of the receptors were investigated using [3H]5-HT 
together with a range of ligands following transient transfection 
of 5-HT~D~ or 5-HTID ~ genes into COS-7 cells. [3H]5-HT bind- 
ing was measured over a range of ligand concentrations (0.025- 
50 nM) and non-specific binding was linear over this range. 
Representative 5-HT saturation binding curves for both recep- 
tors are shown in Fig. 2A and B. Hill slope parameters were 
not significantly different from unity. The pKd estimates (n = 3) 
for 5-HT for the 5-HT~D~ and 5-HT~DB receptors were 
-8.47 + 0.15 (K d = 3.8 nM) and -7.95 + 0.05 (K d = 11.2 riM) 
respectively, with Bm~x values of 0.37 + 0.05 pmol/mg for 
5-HTID~, and 0.87 + 0.12 for 5-HTID p. pICs0 values and Hill 
slope parameters for the competition curves of the ligands are 
given in Table 1. In general Hill slope parameters were less than 
unity, therefore it is invalid to calculate K~ affinity estimates. 
These values show good agreement with the affinity values 
derived from studies on the cloned human receptors, with the 
exception of sumatriptan which has a higher affinity at the 
human 5-HTm~ and 5-HTm~ receptors than at their respective 
rabbit homologues. The rank order of affinity for the rabbit 
5-HT~D~ receptor is: 5-CT>5-HT = metergoline > ketanserin --
sumatriptan > pindolol. For the rabbit 5-HT~D~ receptor the 
order is: 5-CT > 5-HT = metergoline > sumatriptan > ket- 
anserin > pindolol. The low affinity of pindolol at the rabbit 
5-HTmp receptor is consistent with the amino acid sequence 
(see above) predicting a 5-HT1D pharmacology rather than a 
5-HTm pharmacology. Ketanserin displayed an 800-fold 
greater affinity for the rabbit 5-HT~D~ receptor over the 5- 
HT1D~ receptor, as seen with the human receptors [15]. 
4. Discuss ion 
We have cloned the rabbit 5-HT1D ~ and 5-HT~Dp receptor 
genes from genomic DNA using high stringency hybridisation 
with the corresponding human gene probes. The rabbit 
5-HTID ~ receptor gene encodes an open reading frame of 377 
amino acids with high amino acid sequence homology to the 
human, canine and rat receptors. The rabbit 5-HTIDp receptor 
encodes a 390 amino acid protein and, like the 5-HT1D a gene, 
shows high amino acid homology to the human receptor. 
The high degree of conservation of amino acid sequence 
between members of both the 5-HTID = and 5-HT~D¢ subtypes 
suggests evolutionary pressure to maintain structural features 
critical to the biological function of these receptors. For exam- 
ple the putative N-linked glycosylation sites, protein kinase A 
and C recognition sites (Fig. 1A and B) and residues known to 
be involved in monoamine ligand interaction [16] are conserved 
within these two groups of receptors. 
Rodent 5-HT m receptors hare a high degree of amino acid 
Table 1 
plCs0 values for cloned rabbit 5-HT~D~ and 5-HTID ~ receptors 
Compound Rabbit 5-HTjD ~ Human 5-HTID = Rabbit 5-HT~Da Human 5-HT~Dp 
plCs0 + SEM nH+ SEM plCso + SEM plCso + SEM nH + SEM plCso + SEM 
5-HT 8.57 + 0.01 (1) 0.86 + 0.08 8.33 + 0.05 (1) 8.33 + 0.01 (1) 0.70 + 0.04 8.00 + 0.18 (1) 
5-CT 9.08 + 0.02 (0.31) 0.77 + 0.06 9.26 + 0.06 (0.12) 8.44 + 0.01 (0.78) 0.68 + 0.04 8.41 + 0.01 (0.39) 
Metergoline 8.51 + 0.01 (1.15) 0.58 + 0.06 8.64 + 0.13 (0.49) 8.13 + 0.12 (1.6) 0.68 + 0.09 7.62 + 0.01 (2.4) 
Ketanserin 7.49 + 0.25 (12) 0.56 + 0.12 7.36 + 0.06 (1.45) 5.40 + 0.10 (831) 0.72 +_ 0.10 5.27 + 0.01 (537) 
Sumatriptan 7.45 + 0.12 (13) 1.08 + 0.20 8.17 + 0.03 (9.3) 6.52 +_ 0.09 (65) 0.86 + 0.11 7.42 + 0.01 (3.8) 
Pindolol 4.75 + 0.12 (6606) 1.04 + 0.06 4.96 + 0.07 (2344) 4.30 + 0.12 (10715) 1.43 + 0.09 4.96 + 0.04 (1096) 
COS-7 ceils were transfected with expression vectors encoding 5-HTID ~ or 5-HTID ~ receptors. Cell membranes were prepared and 1.5 nM [3H]5-HT 
binding was measured in the presence of a variety of ligands, pICs0 values represent the negative logm concentration f ligands at which 50% of the 
specific bound [3H]5-HT could be displaced, pICs0 values and Hill coefficients (nil) are means + S.E.M. from 4-10 determinations. The values for 
the human 5-HTm= and 5-HT1D a are taken from [15]. Affinity ratios are bracketed below the pICs0 values. 
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sequence identity with human 5-HT~o ~ receptors [3,6,13] but 
have a distinct pharmacology exemplified by a high affinity for 
fl-adrenergic antagonists, e.g. pindolol. The molecular basis for 
this difference has been localised to a threonine residue in TM7 
of the human 5-HTID p receptor. Mutation of this residue to 
asparagine confers a 5-HTls pharmacology with a high affinity 
for pindolol [17]. The presence of a threonine residue in the 
rabbit 5-HT~o~ receptor at this position is consistent with the 
observed low affinity for pindolol at this receptor and restric- 
tion of the 5-HT1B pharmacology to rodents. The rabbit repre- 
sents the second species from which a 5-HT1D~ subtype receptor 
has been characterised atthe molecular level; the human is the 
only other species from which a 5-HTIDp receptor has been 
cloned. 
The pharmacogical profile at the rabbit 5-HT1D~ and 5- 
HTtDa receptors were generally consistent with the data previ- 
ously generated for the human receptors (see Table 1), includ- 
ing the considerably higher affinity of ketanserin for the 5- 
HT~D~ receptor compared with the 5-HT~o~ receptor. However 
sumatriptan displayed a lower affinity for the rabbit receptors, 
particularly for the 5-HTlo~ receptor where it had a 65-fold 
lower affinity than 5-HT, compared with an affinity ratio of 
only 4-fold at the human 5-HTID~ receptor. 
The molecular basis for the higher affinity of sumatriptan for 
the human compared to the rabbit 5-HT~D ~ receptor could be 
addressed by examining the role of the amino acid changes 
between these receptors within the transmembrane domains. 
Construction of chimaeric human-rabbit receptors and site 
directed mutagenesis experiments may provide further insights 
into the molecular basis for this difference. 
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